ArticleThe European journal of health economics : HEPAC : health economics in prevention and care2023

Is ultra-hypo-fractionated radiotherapy more cost-effective relative to conventional fractionation in treatment of prostate cancer? A cost-utility analysis alongside a randomized HYPO-RT-PC trial.

Sun Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.